{"analyses":[{"ciLowerLimit":"0.65","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.05","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.615","paramType":"Hazard Ratio (HR)","paramValue":"1.16","statisticalMethod":"Regression, Cox"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"108"}]}],"title":"Alive (censored)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"25"}]}],"title":"Death (event)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"description":"Alive patients were censored at the date of last follow-up. Causes of death were recorded and reported as a table.","groups":[{"description":"En-bloc resection of surrounding tissues and organs when located within 1 to 2 cm from the surface tumor, even when not infiltrated.\n\ntherapeutic conventional surgery","id":"OG000","title":"Surgery Alone"},{"description":"3D-CRT or IMRT to a dose of 50.4 Gy/28 daily fractions\n\ntherapeutic conventional surgery\n\n3-dimensional conformal radiation therapy","id":"OG001","title":"Preoperative Radiotherapy Followed by En-bloc Surgery"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Overall survival was measured from the date of randomization to the date of death, whatever the cause, up to a maximum of 7 years","title":"Number of Patients Alive","type":"SECONDARY","unitOfMeasure":"Participants"}